Idraparinux or Idrabiotaparinux for Long-Term Venous Thromboembolism Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Open Access

Peer-reviewed

Research Article

Yanzhi Song ,

* E-mail: yandgics@126.com

Affiliation Department of Hematology, BenQ Medical Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Xiaodong Li,

Affiliation Department of Radiotherapy, BenQ Medical Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Settipalli Pavithra,

Affiliation Southeast University, Nanjing, Jiangsu Province, China
⨯
Dong Li

Affiliation Department of Hematology, BenQ Medical Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯

Reader Comments (0)

Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Hemorrhage
Is the Subject Area "Hemorrhage" applicable to this article?

Thanks for your feedback.
Venous thromboembolism
Is the Subject Area "Venous thromboembolism" applicable to this article?

Thanks for your feedback.
Anticoagulant therapy
Is the Subject Area "Anticoagulant therapy" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Deep vein thrombosis
Is the Subject Area "Deep vein thrombosis" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.